News | Remote Monitoring | March 14, 2016

New Biotronik Insertable Cardiac Monitor Available in the U.K. and Ireland

Implantable device provides accurate daily transmission of cardiac electrical data for arrhythmia detection

Biotronik, BioMonitor 2, AF remote monitoring, atrial fibrillation, U.K. and Ireland

March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United Kingdom. The insertable device allows highly accurate and reliable continuous detection of cardiac electrical events.

The monitor is indicated for patients suffering from unexplained syncope, and to detect atrial fibrillation (AF). Diagnosing the irregular heartbeat condition AF is notoriously difficult, as is finding the root cause of syncope — a condition where the patient passes out due to decreased blood flow to the brain. If left untreated, both can be life threatening.

In response, BioMonitor 2 can be inserted under the skin of the patient in a simple procedure. It then records all cardiac electrical events. Data from the device is transmitted directly to the physician via Biotronik Home Monitoring, where they are given an accurate map of the heart’s activity right on their computer screen.

“AF is often so sporadic and unpredictable that it is sometimes impossible to diagnose at the time the patient has symptoms,” commented Riyaz Kaba, M.D., from Ashford and St Peter’s Hospitals, Surrey, and St George’s Hospital, London. “It is similar with syncope. The patient can hardly choose to faint when they are hooked up to an ECG just so we can find out what’s causing it. But, because BioMonitor 2 is always on and always recording, we can see exactly what’s going on with their cardiac rhythm in these precise moments. It’s really unprecedented and the accuracy of the readings has exceeded our expectations. We get a clear picture very early on, meaning necessary treatment can begin earlier.”

As well as its diagnostic benefits, the device has been designed with the patient anatomy in mind. “The insertion procedure is easy for both doctor and patient. It only takes a few minutes,” explained Kaba. “The monitor adapts to the patient’s anatomy, and they’re satisfied with the overall cosmetic result.”

BioMonitor 2 also has Biotronik ProMRI technology and is approved for full-body magnetic resonance imaging (MRI) scans at both the usual 1.5 and ultra-high 3.0 tesla strength. Its average battery life is four years, topping the industry standard by a year.

For more information: www.biotronik.com

Related Content

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Feature | Atrial Fibrillation | July 24, 2019
July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm.
New Technology Improves Atrial Fibrillation Detection After Stroke
News | Atrial Fibrillation | July 19, 2019
A new method of evaluating irregular heartbeats outperformed the approach that’s currently used widely in stroke units...
An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures.

An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures. 

News | Atrial Fibrillation | May 14, 2019 | Dave Fornell, Editor
May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary vei
The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. 

News | Atrial Fibrillation | May 13, 2019
May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce...
More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

News | Atrial Fibrillation | May 13, 2019
May 13, 2019 — A digital screening for...
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

 

Feature | Atrial Fibrillation | January 30, 2019
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral
Aurigen Medical Atrial Fibrillation Device Wins ICI Innovation Award
News | Atrial Fibrillation | December 18, 2018
Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the International...
Overlay Init